Galenica Sante AG (GALE) - Total Liabilities
Based on the latest financial reports, Galenica Sante AG (GALE) has total liabilities worth CHF1.62 Billion CHF (≈ $2.04 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Galenica Sante AG (GALE) cash conversion ratio to assess how effectively this company generates cash.
Galenica Sante AG - Total Liabilities Trend (2013–2024)
This chart illustrates how Galenica Sante AG's total liabilities have evolved over time, based on quarterly financial data. Check GALE asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Galenica Sante AG Competitors by Total Liabilities
The table below lists competitors of Galenica Sante AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Greek Organization of Football Prognostics S.A.
AT:OPAP
|
Greece | €1.75 Billion |
|
China Nonferrous Mining Corporation Limited
STU:3N4
|
Germany | €1.45 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥5.52 Billion |
|
Ho Chi Minh City Development Joint Stock Commercial Bank
VN:HDB
|
Vietnam | ₫852.84 Trillion |
|
Sam Yang Foods
KO:003230
|
Korea | ₩984.28 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Galenica Sante AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Galenica Sante AG (GALE) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.08 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Galenica Sante AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Galenica Sante AG (2013–2024)
The table below shows the annual total liabilities of Galenica Sante AG from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CHF1.52 Billion ≈ $1.92 Billion |
+0.22% |
| 2023-12-31 | CHF1.52 Billion ≈ $1.92 Billion |
+7.18% |
| 2022-12-31 | CHF1.41 Billion ≈ $1.79 Billion |
+2.33% |
| 2021-12-31 | CHF1.38 Billion ≈ $1.75 Billion |
+14.64% |
| 2020-12-31 | CHF1.21 Billion ≈ $1.52 Billion |
-0.37% |
| 2019-12-31 | CHF1.21 Billion ≈ $1.53 Billion |
+30.60% |
| 2018-12-31 | CHF926.49 Million ≈ $1.17 Billion |
-1.09% |
| 2017-12-31 | CHF936.67 Million ≈ $1.18 Billion |
-43.28% |
| 2016-12-31 | CHF1.65 Billion ≈ $2.09 Billion |
+12.07% |
| 2015-12-31 | CHF1.47 Billion ≈ $1.86 Billion |
+0.33% |
| 2014-12-31 | CHF1.47 Billion ≈ $1.86 Billion |
-2.49% |
| 2013-12-31 | CHF1.51 Billion ≈ $1.90 Billion |
-- |
About Galenica Sante AG
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates in two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at h… Read more